Mechanistic description
Age-related synaptic dysfunction is characterized by accumulation of damaged organelles and misfolded proteins due to compromised autophagy-lysosomal pathway efficiency. While TFEB activation increases lysosomal biogenesis, the critical bottleneck in aged synapses may be the impaired fusion between autophagosomes and lysosomes rather than lysosomal abundance alone. This hypothesis proposes that TFEB activation specifically enhances autophagosome-lysosome fusion machinery by upregulating SNARE proteins (STX17, SNAP29, VAMP8) and Rab7 GTPase activity at synaptic terminals. In aged synapses, accumulated oxidative damage disrupts the microtubule network and reduces Rab7-RILP complex formation, preventing efficient autophagosome trafficking to lysosomes. TFEB transcriptionally upregulates not only lysosomal genes but also fusion machinery components, restoring the spatial coupling between autophagosome formation and lysosomal degradation. The intervention would involve targeted TFEB activation through small molecule agonists or optogenetic approaches specifically at synaptic compartments, where the fusion deficit is most pronounced. Evidence would focus on measuring fusion events using dual-fluorescence LC3-LAMP1 assays, monitoring Rab7 activation states, and quantifying SNARE complex formation in aged vs young synaptic preparations. Success would be demonstrated by restored autophagic flux rates, reduced accumulation of p62/SQSTM1 aggregates, and improved synaptic transmission efficiency in aged neurons following TFEB activation.
Evidence for (6)
TFEB overexpression reduces tau aggregation and Aβ toxicity in cellular models
Impaired TFEB nuclear localization observed in AD brain tissue with mTOR hyperactivation
Trehalose enhances lysosomal biogenesis and reduces protein aggregates in neurodegeneration models
Autophagosome accumulation in AD synapses indicates upstream autophagy initiation is intact but downstream lysosomal degradation is blocked
mTOR inhibitors (rapamycin analogs) enable TFEB nuclear translocation
TFEB activation bypasses upstream mTOR dysregulation and directly enhances lysosomal gene expression
Evidence against (6)
TFEB regulates hundreds of genes beyond lysosomal biogenesis including lipid metabolism and inflammatory pathways
TFEB overexpression paradoxically increases neurodegeneration in α-synuclein models via APP-like substrate processing
Global TFEB activation in microglia exacerbates neuroinflammation through enhanced lysosomal antigen presentation
TFEB haploinsufficiency is protective in certain aging paradigms, suggesting a 'Goldilocks' principle
Trehalose acts as chemical chaperone independently of TFEB
Genistein is a broad kinase inhibitor with estrogenic activity
Bayesian persona consensus
scidex.consensus.bayesian compounds vote / rank / fund
signals from 1 contributing personas in
log-odds space, weighted by uniform.
Prior 50%.